Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1111/ajt.16599 http://scihub22266oqcxt.onion/10.1111/ajt.16599 33835707!8251470!33835707     free     free     free Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 265.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 265.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 265.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 265.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Am+J+Transplant 2021 ; 21 (8): 2876-2884 Nephropedia Template TP {{tp|p=33835707|t=2021. Changes in humoral immune response after SARS-CoV-2 infection in liver transplant recipients compared to immunocompetent patients |pdf=|usr=}}{{33835707}} gab.com Text Changes in humoral immune response after SARS-CoV-2 infection in liver transplant recipients compared to immunocompetent patients JO: Am J Transplant http://www.kidney.de/pget.php?&tw=1&pmid=33835707 #FOAvip The protective capacity and duration of humoral immunity after SARS-CoV-2 infection are not yet understood in solid organ transplant recipients. A prospective multicenter study was performed to evaluate the persistence of anti-nucleocapsid IgG antibodies in liver transplant recipients 6 months after coronavirus disease 2019 (COVID-19) resolution. A total of 71 liver transplant recipients were matched with 71 immunocompetent controls by a propensity score including variables with a well-known prognostic impact in COVID-19. Paired case-control serological data were also available in 62 liver transplant patients and 62 controls at month 3 after COVID-19. Liver transplant recipients showed a lower incidence of anti-nucleocapsid IgG antibodies at 3 months (77.4% vs. 100%, p < .001) and at 6 months (63.4% vs. 90.1%, p < .001). Lower levels of antibodies were also observed in liver transplant patients at 3 (p = .001) and 6 months (p < .001) after COVID-19. In transplant patients, female gender (OR = 13.49, 95% CI: 2.17-83.8), a longer interval since transplantation (OR = 1.19, 95% CI: 1.03-1.36), and therapy with renin-angiotensin-aldosterone system inhibitors (OR = 7.11, 95% CI: 1.47-34.50) were independently associated with persistence of antibodies beyond 6 months after COVID-19. Therefore, as compared with immunocompetent patients, liver transplant recipients show a lower prevalence of anti-SARS-CoV-2 antibodies and more pronounced antibody levels decline. Twit Text FOAVip Changes in humoral immune response after SARS-CoV-2 infection in liver transplant recipients compared to immunocompetent patients ????Am J Transplant http://www.kidney.de/pget.php?&tw=1&pmid=33835707 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33835707 #FOAvip English Wikipedia <ref>{{Cite pmid|33835707}}</ref> Changes in humoral immune response after SARS-CoV-2 infection in liver transplant recipients compared to immunocompetent patients #MMPMID33835707 Caballero-Marcos A; Salcedo M; Alonso-Fernandez R; Rodriguez-Peralvarez M; Olmedo M; Graus Morales J; Cuervas-Mons V; Cachero A; Loinaz-Segurola C; Inarrairaegui M; Castells L; Pascual S; Vinaixa-Aunes C; Gonzalez-Grande R; Otero A; Tome S; Tejedor-Tejada J; Alamo-Martinez JM; Gonzalez-Dieguez L; Nogueras-Lopez F; Blanco-Fernandez G; Munoz-Bartolo G; Bustamante FJ; Fabrega E; Romero-Cristobal M; Martin-Mateos R; Del Rio-Izquierdo J; Arias-Milla A; Calatayud L; Marcacuzco-Quinto AA; Fernandez-Alonso V; Gomez-Gavara C; Colmenero J; Munoz P; Pons JA Am J Transplant 2021[Aug]; 21 (8): 2876-2884 PMID33835707show ga The protective capacity and duration of humoral immunity after SARS-CoV-2 infection are not yet understood in solid organ transplant recipients. A prospective multicenter study was performed to evaluate the persistence of anti-nucleocapsid IgG antibodies in liver transplant recipients 6 months after coronavirus disease 2019 (COVID-19) resolution. A total of 71 liver transplant recipients were matched with 71 immunocompetent controls by a propensity score including variables with a well-known prognostic impact in COVID-19. Paired case-control serological data were also available in 62 liver transplant patients and 62 controls at month 3 after COVID-19. Liver transplant recipients showed a lower incidence of anti-nucleocapsid IgG antibodies at 3 months (77.4% vs. 100%, p < .001) and at 6 months (63.4% vs. 90.1%, p < .001). Lower levels of antibodies were also observed in liver transplant patients at 3 (p = .001) and 6 months (p < .001) after COVID-19. In transplant patients, female gender (OR = 13.49, 95% CI: 2.17-83.8), a longer interval since transplantation (OR = 1.19, 95% CI: 1.03-1.36), and therapy with renin-angiotensin-aldosterone system inhibitors (OR = 7.11, 95% CI: 1.47-34.50) were independently associated with persistence of antibodies beyond 6 months after COVID-19. Therefore, as compared with immunocompetent patients, liver transplant recipients show a lower prevalence of anti-SARS-CoV-2 antibodies and more pronounced antibody levels decline. |*COVID-19[MESH] |*Liver Transplantation[MESH] |Female[MESH] |Humans[MESH] |Immunity, Humoral[MESH] |Prospective Studies[MESH] |SARS-CoV-2[MESH]Changes in humoral immune response after SARS-CoV-2 infection in liver(epmc).pdf DeepDyve Pubget Overpricing